Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening

Gastroenterology

Volumn 147, Issue 5, 2014, Pages 1021-1030.e1

  Quintero, Enrique ^a   Carrillo, Marta ^a   Gimeno García, Antonio Z ^a   Hernández Guerra, Manuel ^a   Nicolás Pérez, David ^a   Alonso Abreu, Inmaculada ^a   Díez Fuentes, Maria Luisa ^a   Abraira, Víctor ^b,c  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

Colon Cancer; Colonoscopy Resources; Diagnostic Yield; Familial Colorectal Cancer

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SCREENING; COLONOSCOPY; COLORECTAL ADENOMA; COMPARATIVE STUDY; CONTROLLED STUDY; FAMILY HISTORY; FECAL IMMUNOCHEMICAL TEST; FECES ANALYSIS; FEMALE; FIRST DEGREE RELATIVE; FOLLOW UP; HEREDITARY COLORECTAL CANCER; HUMAN; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCREENING TEST; TECHNOLOGY; ADENOMA; CHEMISTRY; COLON; COLORECTAL NEOPLASMS; EARLY DIAGNOSIS; FECES; GENETIC PREDISPOSITION; GENETICS; HEREDITY; LABORATORY DIAGNOSIS; MIDDLE AGED; PATHOLOGY; PATIENT COMPLIANCE; PEDIGREE; PREDICTIVE VALUE; PROCEDURES; RISK; RISK FACTOR; SPAIN; STATISTICAL MODEL; TIME;

HEMOGLOBIN; TUMOR MARKER;

ADENOMA; ADULT; COLON; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FALSE NEGATIVE REACTIONS; FECES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEMOGLOBINS; HEREDITY; HUMANS; IMMUNOCHEMISTRY; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PATIENT COMPLIANCE; PEDIGREE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; SPAIN; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84908273441     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2014.08.004     Document Type: Article

References (41)

1. A.S. Butterworth, J.P. Higgins, and P. Pharoah Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis Eur J Cancer 42 2006 216 227
2. L.E. Johns, and R.S. Houlston A systematic review and meta-analysis of familial colorectal cancer risk Am J Gastroenterol 96 2001 2992 3003
3. C.S. Fuchs, E.L. Giovannucci, and G.A. Colditz A prospective study of family history and the risk of colorectal cancer N Engl J Med 331 1994 1669 1674
4. D.J. St John, F.T. McDermott, and J.L. Hopper Cancer risk in relatives of patients with common colorectal cancer Ann Intern Med 118 1993 785 790
5. L.A. Boardman, B.W. Morlan, and K.G. Rabe Colorectal cancer risks in relatives of young-onset cases: is risk the same across all first-degree relatives? Clin Gastroenterol Hepatol 5 2007 1195 1198
6. S.C. Ng, J.Y. Lau, and F.K. Chan Increased risk of advanced neoplasms among asymptomatic siblings of patients with colorectal cancer Gastroenterology 144 2013 544 550
7. A. Castells, M. Marzo-Castillejo, and J.J. Mascort [Clinical practice guideline. Prevention of colorectal cancer. 2009 update. Asociación Española de Gastroenterología] Gastroenterol Hepatol 717 2009 E1 E58 [Article in Spanish.]
8. R.E. Davila, E. Rajan, and T.H. Baron ASGE guideline: colorectal cancer screening and surveillance Gastrointest Endosc 63 2006 546 557
9. D.A. Lieberman, D.K. Rex, and S.J. Winawer Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer Gastroenterology 143 2012 844 857
10. D.K. Rex, D.A. Johnson, and J.C. Anderson American College of Gastroenterology guidelines for colorectal cancer screening Am J Gastroenterol 104 2009 739 750
11. D. Ait Ouakrim, T. Lockett, and A. Boussioutas Screening participation for people at increased risk of colorectal cancer due to family history: a systematic review and meta-analysis Fam Cancer 12 2013 459 472
12. L. Bujanda, C. Sarasqueta, and L. Zubiaurre Low adherence to colonoscopy in the screening of first-degree relatives of patients with colorectal cancer Gut 56 2007 1714 1718
13. D. Ait Ouakrim, T. Lockett, and A. Boussioutas Screening practices of Australian men and women categorized as "at or slightly above average risk" of colorectal cancer Cancer Causes Control 23 2012 1853 1864
14. R.J. Courtney, C.L. Paul, and M.L. Carey A population-based cross-sectional study of colorectal cancer screening practices of first-degree relatives of colorectal cancer patients BMC Cancer 13 2013 13
15. F. Ruthotto, F. Papendorf, and G. Wegener Participation in screening colonoscopy in first-degree relatives from patients with colorectal cancer Ann Oncol 18 2007 1518 1522
16. S. Subramanian, M.M. Amonkar, and T.L. Hunt Use of colonoscopy for colorectal cancer screening: evidence from the 2000 National Health Interview Survey Cancer Epidemiol Biomarkers Prev 14 2005 409 416
17. M. Taouqi, I. Ingrand, and M. Beauchant Determinants of participation in colonoscopic screening by siblings of colorectal cancer patients in France BMC Cancer 10 2010 355
18. N. Malila, C. Senore, and P. Armaroli European guidelines for quality assurance in colorectal cancer screening and diagnosis Endoscopy 44 Suppl 3 2012 SE31 SE48
19. A.Z. Gimeno-Garcia, E. Quintero, and D. Nicolas-Perez Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot study Eur J Gastroenterol Hepatol 21 2009 1062 1067
20. R. Hazazi, P. Rozen, and M. Leshno Can patients at high risk for significant colorectal neoplasms and having normal quantitative faecal occult blood test postpone elective colonoscopy? Aliment Pharmacol Ther 31 2010 523 533
21. J.M. Lane, E. Chow, and G.P. Young Interval fecal immunochemical testing in a colonoscopic surveillance program speeds detection of colorectal neoplasia Gastroenterology 139 2010 1918 1926
22. H.F. Vasen, P. Watson, and J.P. Mecklin New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC Gastroenterology 116 1999 1453 1456
23. A. Vilkin, P. Rozen, and Z. Levi Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test Am J Gastroenterol 100 2005 2519 2525
24. C.G. Fraser, J.E. Allison, and S.P. Halloran A proposal to standardize reporting units for fecal immunochemical tests for hemoglobin J Natl Cancer Inst 104 2012 810 814
25. A. Parra-Blanco, D. Nicolas-Perez, and A. Gimeno-Garcia The timing of bowel preparation before colonoscopy determines the quality of cleansing, and is a significant factor contributing to the detection of flat lesions: a randomized study World J Gastroenterol 12 2006 6161 6166
26. J.B. O'Connell, M.A. Maggard, and C.Y. Ko Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging Journal of the National Cancer Institute 96 2004 1420 1425
27. B. Bressler, L.F. Paszat, and Z. Chen Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis Gastroenterology 132 2007 96 102
28. G. Piaggio, D.R. Elbourne, and D.G. Altman Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement JAMA 295 2006 1152 1160
29. E. Christensen Methodology of superiority vs. equivalence trials and non-inferiority trials J Hepatol 46 2007 947 954
30. C. Mehta PN. Proc-StatXact 5 for SAS users: statistical software for exact nonparametric inference 2002 Cytel Incorporated Cambridge, MA
31. W.L. Greene, J. Concato, and A.R. Feinstein Claims of equivalence in medical research: Are they supported by the evidence? Ann Intern Med 132 2000 715 722
32. A. Le Henanff, B. Giraudeau, and G. Baron Quality of reporting of noninferiority and equivalence randomized trials JAMA 295 2006 1147 1151
33. P.A. Bampton, J.J. Sandford, and S.R. Cole Interval faecal occult blood testing in a colonoscopy based screening programme detects additional pathology Gut 54 2005 803 806
34. S.C. Ng, J.Y. Ching, and V. Chan Diagnostic accuracy of faecal immunochemical test for screening individuals with a family history of colorectal cancer Aliment Pharmacol Ther 38 2013 835 841
35. L.G. van Rossum, A.F. van Rijn, and R.J. Laheij Cutoff value determines the performance of a semi-quantitative immunochemical faecal occult blood test in a colorectal cancer screening programme Br J Cancer 101 2009 1274 1281
36. S.J. Stryker, B.G. Wolff, and C.E. Culp Natural history of untreated colonic polyps Gastroenterology 93 1987 1009 1013
37. E. Quintero, A. Castells, and L. Bujanda Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening N Engl J Med 366 2012 697 706
38. I. Castro, J. Cubiella, and C. Rivera Fecal immunochemical test accuracy in familial risk colorectal cancer screening Int J Cancer 134 2013 367 375
39. D.A. Lieberman, D.G. Weiss, and W.V. Harford Five-year colon surveillance after screening colonoscopy Gastroenterology 133 2007 1077 1085
40. European guidelines for quality assurance in colorectal cancer screening and diagnosis 2011 European Commission Brussels
41. Z. Levi, P. Rozen, and R. Hazazi A quantitative immunochemical fecal occult blood test for colorectal neoplasia Ann Intern Med 146 2007 244 255